Sponsor Pipeline

Theradex Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07033598 Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia Leukemia, Myelomonocytic, Chronic Recruiting
Disease Areas
Leukemia (1)
Get alerts when Theradex's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free